Zang EA - Search Results

1

Hepatitis B vaccine in medical staff of hemodialysis units: efficacy and subtype cross-protection.

Szmuness W, Stevens CE, Harley EJ, Zang EA, Alter HJ, Taylor PE, DeVera A, Chen GT, Kellner A. Szmuness W, et al. Among authors: zang ea. N Engl J Med. 1982 Dec 9;307(24):1481-6. doi: 10.1056/NEJM198212093072403. N Engl J Med. 1982. PMID: 6755247 Clinical Trial.

2

Hepatitis B vaccine in patients receiving hemodialysis. Immunogenicity and efficacy.

Stevens CE, Alter HJ, Taylor PE, Zang EA, Harley EJ, Szmuness W. Stevens CE, et al. Among authors: zang ea. N Engl J Med. 1984 Aug 23;311(8):496-501. doi: 10.1056/NEJM198408233110803. N Engl J Med. 1984. PMID: 6235453 Clinical Trial.

3

Hepatitis B vaccine: demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States.

Szmuness W, Stevens CE, Harley EJ, Zang EA, Oleszko WR, William DC, Sadovsky R, Morrison JM, Kellner A. Szmuness W, et al. Among authors: zang ea. N Engl J Med. 1980 Oct 9;303(15):833-41. doi: 10.1056/NEJM198010093031501. N Engl J Med. 1980. PMID: 6997738 Clinical Trial.

4

A controlled clinical trial of the efficacy of the hepatitis B vaccine (Heptavax B): a final report.

Szmuness W, Stevens CE, Zang EA, Harley EJ, Kellner A. Szmuness W, et al. Among authors: zang ea. Hepatology. 1981 Sep-Oct;1(5):377-85. doi: 10.1002/hep.1840010502. Hepatology. 1981. PMID: 7030902 Clinical Trial.

5

The immune response of healthy adults to a reduced dose of hepatitis B vaccine.

Szmuness W, Stevens CE, Harley EJ, Zang EA, Taylor PE, Alter HJ. Szmuness W, et al. Among authors: zang ea. J Med Virol. 1981;8(2):123-9. doi: 10.1002/jmv.1890080206. J Med Virol. 1981. PMID: 7299378

6

Human T-cell lymphotropic virus type III infection in a cohort of homosexual men in New York City.

Stevens CE, Taylor PE, Zang EA, Morrison JM, Harley EJ, Rodriguez de Cordoba S, Bacino C, Ting RC, Bodner AJ, Sarngadharan MG, et al. Stevens CE, et al. Among authors: zang ea. JAMA. 1986 Apr 25;255(16):2167-72. JAMA. 1986. PMID: 3007789

7

Prevalence of viral antibodies and leukocyte abnormalities among blood donors considering themselves at risk of exposure to AIDS.

Pindyck J, Waldman A, Oleszko W, Zang E, Bianco C. Pindyck J, et al. Ann N Y Acad Sci. 1984;437:472-84. doi: 10.1111/j.1749-6632.1984.tb37170.x. Ann N Y Acad Sci. 1984. PMID: 6100006 No abstract available.

8

Measures to decrease the risk of acquired immunodeficiency syndrome transmission by blood transfusion. Evidence of volunteer blood donor cooperation.

Pindyck J, Waldman A, Zang E, Oleszko W, Lowy M, Bianco C. Pindyck J, et al. Transfusion. 1985 Jan-Feb;25(1):3-9. doi: 10.1046/j.1537-2995.1985.25185116497.x. Transfusion. 1985. PMID: 3969698

9

Changes in AIDS risk behavior among intravenous drug abusers in New York City.

Harris RE, Langrod J, Hebert JR, Lowinson J, Zang E, Wynder EL. Harris RE, et al. N Y State J Med. 1990 Mar;90(3):123-6. N Y State J Med. 1990. PMID: 2314716

10

Herpes zoster: a possible early clinical sign for development of acquired immunodeficiency syndrome in high-risk individuals.

Friedman-Kien AE, Lafleur FL, Gendler E, Hennessey NP, Montagna R, Halbert S, Rubinstein P, Krasinski K, Zang E, Poiesz B. Friedman-Kien AE, et al. J Am Acad Dermatol. 1986 Jun;14(6):1023-8. doi: 10.1016/s0190-9622(86)70127-8. J Am Acad Dermatol. 1986. PMID: 3013955 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

62 results

Search Page

Filters